Nomura Holdings Portfolio holdings
AUM
$12.4B
1-Year Return
7.46%
This Quarter Return
+1.41%
1 Year Return
+7.46%
3 Year Return
+19.24%
5 Year Return
+46.14%
10 Year Return
+84.3%
AUM
$13.3B
AUM Growth
-$2.35B
(-15%)
Cap. Flow
-$2.55B
Cap. Flow
% of AUM
-19.2%
Top 10 Holdings %
Top 10 Hldgs %
37.72%
Holding
1,440
New
219
Increased
258
Reduced
346
Closed
435
Top Buys
| 1 |
Tesla
TSLA
|
+$1.01B |
| 2 |
Meta Platforms (Facebook)
META
|
+$280M |
| 3 |
Marathon Petroleum
MPC
|
+$211M |
| 4 |
Coinbase
COIN
|
+$135M |
| 5 |
Crown Castle
CCI
|
+$121M |
Top Sells
| 1 |
Cognizant
CTSH
|
+$942M |
| 2 |
Texas Instruments
TXN
|
+$797M |
| 3 |
CTLT
CATALENT, INC.
CTLT
|
+$595M |
| 4 |
NVIDIA
NVDA
|
+$503M |
| 5 |
Southwest Airlines
LUV
|
+$498M |
Sector Composition
| 1 | Technology | 29.84% |
| 2 | Consumer Discretionary | 17.29% |
| 3 | Communication Services | 6.55% |
| 4 | Healthcare | 5.92% |
| 5 | Energy | 5.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
KB Home
KBH
$4.62B
| $2.2M | 0.01% |
+25,679
| New | +$2.2M |
|
377
Diebold Nixdorf
DBD
$2.23B
| $2.19M | 0.01% |
49,058
-47,402
| -49% | -$2.12M |
|
378
Boston Scientific
BSX
$160B
| $2.19M | 0.01% |
26,089
-81,823
| -76% | -$6.86M |
|
379
Trade Desk
TTD
$25.4B
| $2.16M | 0.01% |
19,732
+4,589
| +30% | +$503K |
|
380
Emergent Biosolutions
EBS
$403M
| $2.16M | 0.01% |
+258,500
| New | +$2.16M |
|
381
Williams-Sonoma
WSM
$24.8B
| $2.16M | ﹤0.01% |
13,921
+11,625
| +506% | +$1.8M |
|
382
TripAdvisor
TRIP
$2.02B
| $2.13M | ﹤0.01% |
147,069
+97,751
| +198% | +$1.42M |
|
383
Chubb
CB
$111B
| $2.1M | ﹤0.01% |
7,293
-39,557
| -84% | -$11.4M |
|
384
iQIYI
IQ
$2.62B
| $2.06M | ﹤0.01% |
719,938
-184,008
| -20% | -$526K |
|
385
FMC
FMC
$4.73B
| $2.06M | ﹤0.01% |
31,174
+5,869
| +23% | +$387K |
|
386
GlobalFoundries
GFS
$18.3B
| $2.05M | ﹤0.01% |
+50,840
| New | +$2.05M |
|
387
Fiserv
FI
$73.5B
| $2.04M | ﹤0.01% |
11,342
-5,863
| -34% | -$1.05M |
|
388
HUB Group
HUBG
$2.28B
| $2.04M | ﹤0.01% |
44,807
+8,194
| +22% | +$372K |
|
389
Bristol-Myers Squibb
BMY
$95.1B
| $2.02M | ﹤0.01% |
38,992
-43,736
| -53% | -$2.26M |
|
|
NVRO
390
DELISTED
NEVRO CORP.
NVRO
| $1.99M | ﹤0.01% |
355,749
+85,745
| +32% | +$479K |
|
391
Shoals Technologies Group
SHLS
$1.19B
| $1.98M | ﹤0.01% |
352,928
+136,898
| +63% | +$768K |
|
392
Las Vegas Sands
LVS
$36.9B
| $1.97M | ﹤0.01% |
39,154
+24,654
| +170% | +$1.24M |
|
393
GE HealthCare
GEHC
$35.7B
| $1.96M | ﹤0.01% |
20,840
-26,970
| -56% | -$2.53M |
|
394
Charter Communications
CHTR
$36B
| $1.96M | ﹤0.01% |
6,035
+1,035
| +21% | +$335K |
|
395
Itron
ITRI
$5.49B
| $1.95M | ﹤0.01% |
+18,298
| New | +$1.95M |
|
396
Aehr Test Systems
AEHR
$754M
| $1.93M | ﹤0.01% |
150,011
-516,170
| -77% | -$6.63M |
|
397
Snap
SNAP
$12.2B
| $1.91M | ﹤0.01% |
178,970
-84,257
| -32% | -$902K |
|
398
Evolent Health
EVH
$1.12B
| $1.9M | ﹤0.01% |
67,246
+16,733
| +33% | +$473K |
|
399
Cal-Maine
CALM
$5.41B
| $1.89M | ﹤0.01% |
+25,298
| New | +$1.89M |
|
400
Allstate
ALL
$52.8B
| $1.87M | ﹤0.01% |
9,845
-11,797
| -55% | -$2.24M |
|